These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9554033)

  • 1. Characterization of natural suppressor cells in human bone marrow.
    Sugiura K; Pahwa S; Yamamoto Y; Borisov K; Pahwa R; Nelson RP; Ishikawa J; Iguchi T; Oyaizu N; Good RA; Ikehara S
    Stem Cells; 1998; 16(2):99-106. PubMed ID: 9554033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen.
    Sugiura K; Ikehara S; Inaba M; Haraguchi S; Ogata H; Sardiña EE; Sugawara M; Ohta Y; Good RA
    Exp Hematol; 1992 Feb; 20(2):256-63. PubMed ID: 1531958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
    Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors.
    Ishii T; Nishihara M; Ma F; Ebihara Y; Tsuji K; Asano S; Nakahata T; Maekawa T
    J Immunol; 1999 Oct; 163(7):3612-20. PubMed ID: 10490954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
    Young MR; Wright MA; Pandit R
    J Immunol; 1997 Jul; 159(2):990-6. PubMed ID: 9218621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-1 supports induction of hematopoietic activity in human CD34- bone marrow cells.
    Nakamura Y; Yahata T; Muguruma Y; Uno T; Sato T; Matsuzawa H; Kato S; Shirasugi Y; Hotta T; Ando K
    Exp Hematol; 2007 Dec; 35(12):1872-83. PubMed ID: 17923243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.
    Pyrovolaki K; Mavroudi I; Papadantonakis N; Velegraki M; Ximeri M; Kalpadakis C; Gvazava G; Klaus M; Eliopoulos GD; Papadaki HA
    Eur J Haematol; 2007 Dec; 79(6):531-8. PubMed ID: 17961177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
    Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
    Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
    Vercauteren S; Zapf R; Sutherland H
    Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor receptor profile of CD34 cells in normal bone marrow, cord blood and mobilized peripheral blood.
    De Waele M; Renmans W; Asosingh K; Vander Gucht K; Van Riet I
    Eur J Haematol; 2004 Mar; 72(3):193-202. PubMed ID: 14962238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
    Liesveld JL; Harbol AW; Belanger T; Rosell KE; Abboud CN
    Blood Cells Mol Dis; 2000 Aug; 26(4):261-75. PubMed ID: 11042027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts.
    van Lochem EG; van der Velden VH; Wind HK; te Marvelde JG; Westerdaal NA; van Dongen JJ
    Cytometry B Clin Cytom; 2004 Jul; 60(1):1-13. PubMed ID: 15221864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.